Neuroactive steroids of the androstane and pregnane series
AssigneeEuro-Celtique S.A.
InventorsRavindra B. Upasani, David B. Fick, Derk J. Hogenkamp, Nancy C. Lan
Life of this patent
Estimating the term…
Loading patent…
AssigneeEuro-Celtique S.A.
InventorsRavindra B. Upasani, David B. Fick, Derk J. Hogenkamp, Nancy C. Lan
Estimating the term…
The invention relates to 3α-hydroxy, 17-(un)substituted derivatives of the androstane series and 3α-hydroxy, 21-substituted derivatives of the pregnane series. These derivatives are capable of acting at a recently identified site on the GRC, thereby modulating brain excitability in a manner that will alleviate stress, anxiety, insomnia, mood disorders that are amenable to GRC-active agents (such as depression) and seizure activity. The steroid derivatives of this invention are those having the general structural Formula: wherein R, R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are farther defined herein and the dotted lines are single or double bonds. The structure includes androstanes, pregnanes (R4=methyl), 19-norandrostanes, and norpregnanes (R4=H).
A compound of the formula:
A compound selected from the group consisting of 3α-hydroxy-3β-methyl-21-(quinolin-6-yloxy)-5α-pregnan-20-one N-methyl iodide;
Dependencies are inferred from the claim text.